Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Deficit) (Details Narrative)

v3.25.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 3 Months Ended
Feb. 26, 2025
Mar. 31, 2025
Dec. 31, 2024
May 23, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock, shares authorized   250,000,000 250,000,000  
Common stock, par value   $ 0.001 $ 0.001  
Preferred stock, shares authorized   15,000,000 15,000,000  
Preferred stock, par value   $ 0.01 $ 0.01  
Proceeds from private placement $ 686,000      
Other offering expenses $ 70,000      
Placement agents 302,069     21,145
Exercise price $ 2.8375      
Warrant term 5 years      
Equity issuance cost   $ 1,100,000    
Series C Preferred Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Preferred stock, par value   $ 0.01    
Preferred stock, shares issued   96,230 96,230  
Preferred stock, shares outstanding   96,230 96,230  
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Share price $ 4.35      
Inducement Warrants [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Placement agents 604,138      
Exercise price $ 2.27      
Series A Inducement Warrants [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Placement agents 302,069      
Exercise price $ 2.02      
Warrant term 5 years      
Series B Inducement Warrants [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Placement agents 302,069      
Exercise price $ 2.02      
Warrant term 18 months